🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06296017
Recruiting Not applicable

Effectiveness of Conservative Interventions in the Treatment of Trigger Finger

NCT06296017 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-10-02
Last updated
2026-08-05

Condition(s) studied

Trigger FingerStenosing Tenosynovitis

Investigational drug(s) / intervention(s)

Experimental: Extracorporeal Shock Wave TherapyTrigger Finger SplintExtracorporeal Shock Wave Therapy+ Trigger Finger Splint

Experimental: Extracorporeal Shock Wave Therapy: Extracorporeal Shock Wave Therapy (ESWT for short) application will be performed on A1 pulley at 15 Hz, 1000 shock wave impulses, and 2.0 bar level, for a total of 5 sessions, one week apart.

Trigger Finger Splint: A trigger finger splint that immobilizes the MCF joint will be recommended for the splint treatment group. The patient will be asked to use this splint throughout the day for 8 weeks.

Extracorporeal Shock Wave Therapy+ Trigger Finger Splint: Extracorporeal Shock Wave Therapy (ESWT for short) application will be performed on A1 pulley at 15 Hz, 1000 shock wave impulses, and 2.0 bar level, for a total of 5 sessions, one week apart. Also, A trigger finger splint that immobilizes the MCF joint will be recommended.

Study summary

There is no study in the literature comparing the effectiveness of ESWT and splint therapy, which are the most commonly used approaches in the treatment of Trigger Finger (TF). The aim in this study is to investigate the effectiveness of ESWT and splint therapy used in the treatment of TF.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Volunteering * Being between the ages of 18-65 * Being diagnosed with stage 1 or stage 2 (according to the Froimson classification) trigger finger * Having the language and cognitive skills to answer the questionnaires used in the evaluation Exclusion Criteria: * Being pregnant * Having an inflammatory disorder * Having had surgery on the hand/wrist * Having a neurological disease * NSAIDs, painkillers, etc. being on medication * De Quervain's tenosynovitis, carpal tunnel syndrome

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Feray Karademir Ankara Turkey (Türkiye) Recruiting

More Hacettepe University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06296017 on ClinicalTrials.gov ↗ ← All trials in Turkey